(i) Technology and Commercial Collaboration
At OncoMark we are open to considering Partnerships or Joint ventures that will enable optimal platform selection and the widest possible commercial distribution and clinical uptake of our products
(ii) R&D Collaboration: Our Commitment to R&D Collaboration - Building Value
At OncoMark, we are committed to building value through partnering via:
- Actively pursuing new licensing opportunities in cancer biomarkers.
- Biomarker validation for predictive applications.
- Biomarker validation for prognostic aplication.
- Finding suitable partners for our R&D projects..